{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:08:47Z","timestamp":1792166927982,"version":"4.4.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.urolonc.2024.10.035","type":"journal-article","created":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T12:42:53Z","timestamp":1732538573000},"page":"191.e1-191.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The role of intravesical chemotherapy following nephroureterectomy in upper tract urothelial carcinoma: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3418-5202","authenticated-orcid":false,"given":"Stefano","family":"Moretto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Piccolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gallioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Contieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolomaria","family":"Buffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Lughezzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Breda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Baboudjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas WG","family":"van Rhijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Roupret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Uleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Pradere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.urolonc.2024.10.035_bib0001","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2024.10.035_bib0002","series-title":"EAU guidelines, Edn. presented at the 39th EAU Annual Congress Paris","article-title":"EAU guidelines on Non-muscle-invasive bladder cancer (T1, T1 and CIS)","author":"Gontero","year":"2024"},{"issue":"1","key":"10.1016\/j.urolonc.2024.10.035_bib0003","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.eururo.2023.03.013","article-title":"European Association of Urology Guidelines on upper urinary tract urothelial carcinoma: 2023 update","volume":"84","author":"Roupr\u00eat","year":"2023","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2024.10.035_bib0004","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.eururo.2014.11.035","article-title":"A systematic review and meta-analysis of clinicopathologic factors linked to intravesical recurrence after radical nephroureterectomy to treat upper tract urothelial carcinoma","volume":"67","author":"Seisen","year":"2015","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2024.10.035_bib0005","article-title":"Single-dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma","volume":"5","author":"Hwang","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.urolonc.2024.10.035_bib0006","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.eururo.2011.05.064","article-title":"Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial)","volume":"60","author":"O'Brien","year":"2011","journal-title":"Eur Urol"},{"issue":"11","key":"10.1016\/j.urolonc.2024.10.035_bib0007","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1200\/JCO.2012.45.2128","article-title":"Prospective randomized phase II trial of a single early intravesical instillation of pirarubicin (THP) in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma: the THP Monotherapy Study Group trial","volume":"31","author":"Ito","year":"2013","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"6","key":"10.1016\/j.urolonc.2024.10.035_bib0008","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/JU.0000000000003480","article-title":"Diagnosis and management of non-metastatic upper tract urothelial carcinoma: AUA\/SUO guideline","volume":"209","author":"Coleman","year":"2023","journal-title":"J Urol"},{"issue":"10","key":"10.1016\/j.urolonc.2024.10.035_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2022.06.006","article-title":"Practice trends for perioperative intravesical chemotherapy in upper tract urothelial carcinoma: Low but increasing utilization during minimally invasive nephroureterectomy","volume":"40","author":"Kenigsberg","year":"2022","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2024.10.035_bib0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.euros.2020.10.003","article-title":"Postoperative chemotherapy bladder instillation after radical nephroureterectomy: results of a european survey from the young academic urologist urothelial cancer group","volume":"22","author":"Dob\u00e9","year":"2020","journal-title":"Eur Urol Open Sci"},{"issue":"9","key":"10.1016\/j.urolonc.2024.10.035_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2020.05.002","article-title":"Intraoperative prophylactic intravesical chemotherapy to reduce bladder recurrence following radical nephroureterectomy","volume":"38","author":"Freifeld","year":"2020","journal-title":"Urol Oncol"},{"issue":"7","key":"10.1016\/j.urolonc.2024.10.035_bib0012","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3390\/jcm8071059","article-title":"Intravesical chemotherapy after radical nephroureterectomy for primary upper tract urothelial carcinoma: a systematic review and network meta-analysis","volume":"8","author":"Yoo","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.urolonc.2024.10.035_bib0013","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.urolonc.2024.10.035_bib0014","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.urolonc.2024.10.035_bib0015","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.urolonc.2024.10.035_bib0016","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.eururo.2017.08.016","article-title":"Key steps in conducting systematic reviews for underpinning clinical practice guidelines: methodology of the European Association of Urology","volume":"73","author":"Knoll","year":"2018","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2024.10.035_bib0017","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.eururo.2018.12.014","article-title":"Guidelines for reporting of statistics for clinical research in urology","volume":"75","author":"Assel","year":"2019","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2024.10.035_bib0018","first-page":"212","article-title":"Prophylactic intravesical instillation of mitomycin C and cytosine arabinoside for prevention of recurrent bladder tumors following surgery for upper urinary tract tumors: a prospective randomized study","volume":"8","author":"Sakamoto","year":"2001","journal-title":"Int J Urol Off J Jpn Urol Assoc"},{"issue":"11","key":"10.1016\/j.urolonc.2024.10.035_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166884","article-title":"Epidermal growth factor receptor and Ki-67 as predictive biomarkers identify patients who will be more sensitive to intravesical instillations for the prevention of bladder cancer recurrence after radical nephroureterectomy","volume":"11","author":"Long","year":"2016","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.urolonc.2024.10.035_bib0020","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1159\/000451004","article-title":"Prevention of recurrent bladder tumors after nephroureterectomy for primary upper urinary tract urothelial carcinoma: an individualized selection strategy based on patient risk stratification is needed","volume":"98","author":"Long","year":"2017","journal-title":"Urol Int"},{"issue":"6","key":"10.1016\/j.urolonc.2024.10.035_bib0021","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/bju.15162","article-title":"Safety and feasibility of early single-dose mitomycin C bladder instillation after robot-assisted radical nephroureterectomy","volume":"126","author":"Gulamhusein","year":"2020","journal-title":"BJU Int"},{"issue":"8","key":"10.1016\/j.urolonc.2024.10.035_bib0022","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1464-410X.2009.08836.x","article-title":"Pathological characteristics and clinical course of bladder tumour developing after nephroureterectomy","volume":"105","author":"Abe","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2024.10.035_bib0023","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1755368","article-title":"Assessment of therapeutic benefit and option strategy on intravesical instillation for preventing bladder cancer recurrence after radical nephroureterectomy in patients with upper urinary tract urothelial carcinoma","volume":"2022","author":"Fan","year":"2022","journal-title":"J Oncol"},{"issue":"9","key":"10.1016\/j.urolonc.2024.10.035_bib0024","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/jjco\/hyx085","article-title":"Efficacy of early ureteral ligation on prevention of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma: a prospective single-arm multicenter clinical trial","volume":"47","author":"Yamashita","year":"2017","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.urolonc.2024.10.035_bib0025","doi-asserted-by":"crossref","DOI":"10.1177\/1533033819844483","article-title":"A comparison of different prophylactic intravesical chemotherapy regimens for bladder cancer recurrence after nephroureterectomy for primary upper tract urothelial carcinomas: a retrospective 2-center study","volume":"18","author":"Huang","year":"2019","journal-title":"Technol Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.urolonc.2024.10.035_bib0026","doi-asserted-by":"crossref","first-page":"e1108","DOI":"10.1016\/j.clgc.2019.07.019","article-title":"Single versus maintenance intravesical chemotherapy for the prevention of bladder recurrence after radical nephroureterectomy for upper tract urothelial carcinoma: a randomized clinical trial","volume":"17","author":"Harraz","year":"2019","journal-title":"Clin Genitourin Cancer"},{"issue":"3","key":"10.1016\/j.urolonc.2024.10.035_bib0027","doi-asserted-by":"crossref","first-page":"877","DOI":"10.4143\/crt.2023.1219","article-title":"Single early intravesical instillation of epirubicin for preventing bladder recurrence after nephroureterectomy in upper urinary tract urothelial carcinoma","volume":"56","author":"Lee","year":"2024","journal-title":"Cancer Res Treat"},{"issue":"8","key":"10.1016\/j.urolonc.2024.10.035_bib0028","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.21037\/tau-23-112","article-title":"Immediate gemcitabine bladder instillation following bladder closure during robotic-assisted radical nephroureterectomy: a multi-institutional report of feasibility and initial outcomes","volume":"12","author":"Said","year":"2023","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.urolonc.2024.10.035_bib0029","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.euros.2021.09.013","article-title":"Intraoperative mitomycin c bladder instillation during radical nephroureterectomy is feasible and safe","volume":"34","author":"Nadler","year":"2021","journal-title":"Eur Urol Open Sci"},{"issue":"4","key":"10.1016\/j.urolonc.2024.10.035_bib0030","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s00345-023-04316-z","article-title":"A 6-month maintenance schedule of mitomycin C after radical nephroureterectomy for upper tract urothelial carcinoma for the prevention of intravesical recurrence: a retrospective, single center study","volume":"41","author":"van Wijngaarden","year":"2023","journal-title":"World J Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2024.10.035_bib0031","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000350508","article-title":"Prophylactic intravesical chemotherapy to prevent bladder tumors after nephroureterectomy for primary upper urinary tract urothelial carcinomas: a systematic review and meta-analysis","volume":"91","author":"Fang","year":"2013","journal-title":"Urol Int"},{"issue":"8879","key":"10.1016\/j.urolonc.2024.10.035_bib0032","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/0140-6736(93)92066-3","article-title":"Metachronous multifocal development of urothelial cancers by intraluminal seeding","volume":"342","author":"Habuchi","year":"1993","journal-title":"Lancet Lond Engl"},{"issue":"6","key":"10.1016\/j.urolonc.2024.10.035_bib0033","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/S0022-5347(06)00256-4","article-title":"Multifocal urothelial cancers with the mutator phenotype are of monoclonal origin and require panurothelial treatment for tumor clearance","volume":"175","author":"Catto","year":"2006","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2024.10.035_bib0034","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1097\/01.ju.0000129541.23460.48","article-title":"Multifocal transitional cell carcinoma of the bladder and upper urinary tract: molecular screening of clonal origin by characterizing CD44 alternative splicing patterns","volume":"172","author":"Miyake","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2024.10.035_bib0035","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/00005392-200102000-00092","article-title":"Distinct microsatellite alterations in upper urinary tract tumors and subsequent bladder tumors","volume":"165","author":"Takahashi","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2024.10.035_bib0036","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.euros.2023.01.004","article-title":"Bladder recurrence following upper tract surgery for urothelial carcinoma: a contemporary review of risk factors and management strategies","volume":"49","author":"Mertens","year":"2023","journal-title":"Eur Urol Open Sci"},{"issue":"6","key":"10.1016\/j.urolonc.2024.10.035_bib0037","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.eururo.2009.12.032","article-title":"Oncologic outcomes following three different approaches to the distal ureter and bladder cuff in nephroureterectomy for primary upper urinary tract urothelial carcinoma","volume":"57","author":"Li","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2024.10.035_bib0038","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/JU.0000000000001834","article-title":"The impact of upper tract urothelial carcinoma diagnostic modality on intravesical recurrence after radical nephroureterectomy: a single institution series and updated meta-analysis","volume":"206","author":"Sharma","year":"2021","journal-title":"J Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924007154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924007154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T23:39:02Z","timestamp":1744414742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143924007154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1078143924007154"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.10.035","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of intravesical chemotherapy following nephroureterectomy in upper tract urothelial carcinoma: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.10.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}